Novel bradykinin antagonist dimers for the treatment of human lung cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel bradykinin antagonist dimers for the treatment of human lung cancers

Published:1996-06 Issue:1-3 Volume:33 Page:201-204
ISSN:0162-3109
Container-title:Immunopharmacology
language:en
Short-container-title:Immunopharmacology

Author:

Chan Daniel,Gera Lajos,Helfrich Barbara,Helm Karen,Stewart John,Whalley Eric,Bunn Paul

Publisher

Elsevier BV

Subject

Pharmacology

Reference7 articles.

1. Molecular Biology and Pharmacology of Bradykinin Receptors;Burch;Landes Comp,1993

2. A new class of bradykinin antagonists containing indanylglycine

3. A new class of potent bradykinin antagonist dimers

4. The Endocrine Lung in Health and Disease;Becker;Saunders,1984

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide Chemistry's Contribution to the Treatment of the Majority of Serious Illnesses: Peptide Antitumors.;Egyptian Journal of Chemistry;2021-07-14

2. Kinin receptors as targets for cancer therapy;Expert Opinion on Therapeutic Targets;2012-02-18

3. Synthesis and pharmacological evaluation of dimer derivatives of the bradykinin receptor antagonist HOE-140;The Journal of Peptide Research;2009-01-12

4. Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at theC-terminus;Journal of Peptide Science;2007

5. Bradykinin in Solid-phase Peptide Synthesis;International Journal of Peptide Research and Therapeutics;2006-10-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP